Cargando…

DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance

BACKGROUND: Associations between BMI and DNA methylation of hypoxia-inducible factor 3-alpha (HIF3A) in both blood cells and subcutaneous adipose tissue (SAT) have been reported. In this study, we investigated associations between BMI and HIF3A DNA methylation in the blood and SAT from the same indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Main, Ailsa Maria, Gillberg, Linn, Jacobsen, Anna Louisa, Nilsson, Emma, Gjesing, Anette Prior, Hansen, Torben, Pedersen, Oluf, Ribel-Madsen, Rasmus, Vaag, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010678/
https://www.ncbi.nlm.nih.gov/pubmed/27594926
http://dx.doi.org/10.1186/s13148-016-0258-6
_version_ 1782451715255042048
author Main, Ailsa Maria
Gillberg, Linn
Jacobsen, Anna Louisa
Nilsson, Emma
Gjesing, Anette Prior
Hansen, Torben
Pedersen, Oluf
Ribel-Madsen, Rasmus
Vaag, Allan
author_facet Main, Ailsa Maria
Gillberg, Linn
Jacobsen, Anna Louisa
Nilsson, Emma
Gjesing, Anette Prior
Hansen, Torben
Pedersen, Oluf
Ribel-Madsen, Rasmus
Vaag, Allan
author_sort Main, Ailsa Maria
collection PubMed
description BACKGROUND: Associations between BMI and DNA methylation of hypoxia-inducible factor 3-alpha (HIF3A) in both blood cells and subcutaneous adipose tissue (SAT) have been reported. In this study, we investigated associations between BMI and HIF3A DNA methylation in the blood and SAT from the same individuals, and whether HIF3A gene expression in SAT and skeletal muscle biopsies showed associations with BMI and insulin resistance. Furthermore, we aimed to investigate gender specificity and heritability of these traits. METHODS: We studied 137 first-degree relatives of type 2 diabetes (T2D) patients from 48 families, from whom we had SAT and muscle biopsies. DNA methylation of four CpG sites in the HIF3A promoter was analyzed in the blood and SAT by pyrosequencing, and HIF3A gene expression was analyzed in SAT and muscle by qPCR. An index of whole-body insulin sensitivity was estimated from oral glucose tolerance tests. RESULTS: BMI was associated with HIF3A methylation at one CpG site in the blood, and there was a positive association between the blood and SAT methylation levels at a different CpG site within the individuals. The SAT methylation level did not correlate with HIF3A gene expression. Interestingly, HIF3A expression in SAT, but not in muscle, associated negatively with BMI and whole-body insulin resistance. We found a significant effect of familiality on HIF3A methylation levels in the blood and HIF3A expression levels in skeletal muscle. CONCLUSIONS: Our findings are in line with the previously reported link between BMI and DNA methylation of HIF3A in the blood. The tissue-specific results of HIF3A gene expression indicate that SAT is the more functional tissue in which a low expression may adversely affect whole-body insulin sensitivity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0258-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5010678
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50106782016-09-04 DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance Main, Ailsa Maria Gillberg, Linn Jacobsen, Anna Louisa Nilsson, Emma Gjesing, Anette Prior Hansen, Torben Pedersen, Oluf Ribel-Madsen, Rasmus Vaag, Allan Clin Epigenetics Research BACKGROUND: Associations between BMI and DNA methylation of hypoxia-inducible factor 3-alpha (HIF3A) in both blood cells and subcutaneous adipose tissue (SAT) have been reported. In this study, we investigated associations between BMI and HIF3A DNA methylation in the blood and SAT from the same individuals, and whether HIF3A gene expression in SAT and skeletal muscle biopsies showed associations with BMI and insulin resistance. Furthermore, we aimed to investigate gender specificity and heritability of these traits. METHODS: We studied 137 first-degree relatives of type 2 diabetes (T2D) patients from 48 families, from whom we had SAT and muscle biopsies. DNA methylation of four CpG sites in the HIF3A promoter was analyzed in the blood and SAT by pyrosequencing, and HIF3A gene expression was analyzed in SAT and muscle by qPCR. An index of whole-body insulin sensitivity was estimated from oral glucose tolerance tests. RESULTS: BMI was associated with HIF3A methylation at one CpG site in the blood, and there was a positive association between the blood and SAT methylation levels at a different CpG site within the individuals. The SAT methylation level did not correlate with HIF3A gene expression. Interestingly, HIF3A expression in SAT, but not in muscle, associated negatively with BMI and whole-body insulin resistance. We found a significant effect of familiality on HIF3A methylation levels in the blood and HIF3A expression levels in skeletal muscle. CONCLUSIONS: Our findings are in line with the previously reported link between BMI and DNA methylation of HIF3A in the blood. The tissue-specific results of HIF3A gene expression indicate that SAT is the more functional tissue in which a low expression may adversely affect whole-body insulin sensitivity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0258-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-02 /pmc/articles/PMC5010678/ /pubmed/27594926 http://dx.doi.org/10.1186/s13148-016-0258-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Main, Ailsa Maria
Gillberg, Linn
Jacobsen, Anna Louisa
Nilsson, Emma
Gjesing, Anette Prior
Hansen, Torben
Pedersen, Oluf
Ribel-Madsen, Rasmus
Vaag, Allan
DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title_full DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title_fullStr DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title_full_unstemmed DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title_short DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance
title_sort dna methylation and gene expression of hif3a: cross-tissue validation and associations with bmi and insulin resistance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010678/
https://www.ncbi.nlm.nih.gov/pubmed/27594926
http://dx.doi.org/10.1186/s13148-016-0258-6
work_keys_str_mv AT mainailsamaria dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT gillberglinn dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT jacobsenannalouisa dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT nilssonemma dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT gjesinganetteprior dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT hansentorben dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT pedersenoluf dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT ribelmadsenrasmus dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance
AT vaagallan dnamethylationandgeneexpressionofhif3acrosstissuevalidationandassociationswithbmiandinsulinresistance